Depends on many factors or course. Other gains/losses you have, do you need/want the taxable income for this year (only a few more days left you might want to wait) etc? Taking some off the table on a jump like this certainly isn't a bad idea, especially if you can play with the houses money. :)
Why would you ask that question? Charles Schwab & Merrill both have them. Now what? Are you going to run down and open an account if you don't already have one there? If you do have one there, just check for yourself. Guys like TD (yes I have an account there too), Scottrade etc. are known for retail trading. They don't do plenty of stuff that the larger market makers etc. Scottrade doesn't even allow shorting after hours. When I asked why, do you want to know what they told me?
"We don't know if we have the inventory to borrow from after hours." What?????????? So I can short it at 3:59 pm......but not at 4:09 because you don't know if you have the shares to lend? What do you do, turn of the lights and shut down your servers @ 4:00 pm?
Retail is always last in line for anything good. Hot IPO's....or a good short...it's always the same.
If you're 81 then you've seen oil under 20, not just 40. Gas wars and oil wars were actually quite common before OPEC and now that OPEC's stranglehold on the world's supply has been drastically reduced it's not totally crazy to think we could see the 40's again. It's hard to imagine a long term chart that looks worse than this one.
@Smelky....I hope you make a killing on your calls but I do have to throw a little cold water (reality) on your dreams and calculations. If you own the June 200's @ 13.50 and (let's just say the stock gets a partnership, bid, whatever) and the stock moves from it's current level to $250 a share, say within the next six months.
The options you own will not rise 100 points along with the stock. Your options are almost 60 points out of the money. Depending on how long it takes (time value decay), the options could still lose money as the stock rises, if it takes until next July to get there. You don't accrue any intrinsic value at all for the next 60 points. Let's just say for some fun that something comes through during the next six months and next May ICPT is once again trading about $250. That would move the price of the June 200's to around $52-$60 Sure it's four times what you paid, and it's good money, but probably not the killing you expected.
Really? When ICPT was $300 FBR put their price at $175. everybody laughed. It went there. It went back to 250 and FBR said AGAIN, it would go to $175, it did AGAIN a second time....they then lowered it to $125 and everybody laughed, and it hit 128 today (they ain't laughing now)....
All it means is that most of the tax loss selling is over and GS....the MM's...and the ANALysts are loaded with a big position to squeeze a few points out of the shorts.
Baird Starts Intercept Pharmaceuticals (ICPT) at Outperform; Sentiment Has Gotten Too Negative
4:08 PM ET, 12/03/2014 - StreetInsider
Baird initiates coverage on Intercept Pharmaceuticals (NASDAQ: ICPT) with a Outperform rating and a price target of $258.00.
Analyst Brian Skorney commented, "While not ignoring legitimate concerns about the risk/benefit of lead asset, OCA, in NASH, we think the level of negativity implied by the stock price has gone well beyond compensating for these issues. We believe the PBC indication provides a low-risk backstop to valuation and see the risk-reward on the blockbuster NASH indication as being priced very attractively here."
For an analyst ratings summary and ratings history on Intercept Pharmaceuticals click here. For more ratings news on Intercept Pharmaceuticals click here.
Shares of Intercept Pharmaceuticals closed at $136.19 yesterday.
Price Performance Comparison
The company insiders form the company and get shares dirt cheap, including options to buy more.
The venture capital and hedge fund guys come in and supply seed financing.
The company IPO's were insiders and the hedge fund guys make a fortune selling those cheap shares @ a much higher price to the public. At least those that buy @ the IPO price get a few crumbs, but those that buy after the IPO take on the most risk because they have bought at a much higher price per share.
The price moves up as mutual funds and indexes buy. These are the guys that buy the secondary offering as the insiders and initial investors get out, but remember they aren't buying it with their own $$$, they are buying it with OPM (other peoples money).
The price eventually gets to an unsustainable level when the shorting begins. The company disappoints and the hedgies pile on the shorts driving down the price. If the company has a product or service that appears to be successful an acquirer may show up when the price gets low enough.
In the end...the insiders and the hedge funds get $$$$ The analysts and brokers make $$$ by constantly changing their ratings to move the stock in one direction or the other. If the deal works an acquirer such as GILD may or may not make $$$ based on the success of the product.
In the end who losses the $$$ that the insiders and hedgies make? Ahh yes....that would be who always losses. The small investor and the mutual fund holders...the 401K types. Under the cover of all those fees is were the real risk is transferred to the unsuspecting.
GLA.....I really hope that a buy out will occur.
Yet even with this news the stock continues to shed 3% after falling $100 in less than two weeks. Of course GILD has noticed, they'll soon be able to offer $200 or less for the shares and they'll be standing in line to sell it to them.
And what would they tell you then that they haven't already told you now as the stock tanked 30%? The outlook looks bright etc...etc...etc.....we still have more stock to sell?
If the float is 13 million and they traded over 4 million on Friday....what part of a quarter don't you understand? These sellers either A) dumped @ a loss because they think it's going lower....or B)...they got in early enough to sell and preserve some of the profits they did have. Either way....it ain't good. Management is still selling....early investors are too...
The other times you saw this kind of volume was on a general market (and biotech in particular sell off)....not with the market making new highs. It bounced almost immediately. This is company specific....with the drop even bigger than in the past.
Remember when it popped over $100 on August 12th and the insiders couldn't sell it fast enough?
So they have no debt....so what.......they have no earnings either and they're burning that
cash @ over $10 million a month.
Any article or accounting loss that drops market value by BILLIONS isn't just noise. They traded a quarter of the entire float.